Stock TXG 10X GENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News 10x Genomics, Inc.

Equities

TXG

US88025U1097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
26.9 USD -2.25% Intraday chart for 10x Genomics, Inc. -7.08% -51.93%
Apr. 18 Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating MT
Mar. 26 10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating
MT
Petition Denied For Lacking Section 112(f) Construction And Fintiv
AQ
The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?
AQ
UPC Court Of Appeal Overturns Preliminary Injunction In Its First Substantive Decision
AQ
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
PR
UPC Court Of Appeal Reverses Preliminary Injunction In First Substantive Decision
AQ
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
PR
10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay
CI
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
PR
10X Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
CI
Vizgen Announces Denial of 10x Genomics Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted against 10x's Xenium Platform
AQ
10x Genomics Launches Two New Products With Single Cell Technology
MT
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
PR
10x Genomics, Inc. Begins Commercial Shipments of Chromium GEM-X Products
CI
Element Biosciences Announces Senior Vice President of Global Sales and Support
AQ
Transcript : 10x Genomics, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 02:50 PM
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating
MT
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
PR
Stifel Cuts Price Target on 10x Genomics to $63 From $68, Maintains Buy Rating
MT
10x Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TXG Stock
  4. News 10x Genomics, Inc.